Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amgen Inc. (AMGN)

241.49   0.99 (0.41%) 01-17 16:00
Open: 242.11 Pre. Close: 240.5
High: 242.14 Low: 239.27
Volume: 2,311,611 Market Cap: 143489M
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 242.317 - 243.466 243.466 - 244.544
Low: 236.279 - 237.624 237.624 - 238.887
Close: 239.309 - 241.397 241.397 - 243.357

Technical analysis

as of: 2020-01-17 4:33:52 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 286.15     One year: 334.22
Support: Support1: 238.24    Support2: 234.06
Resistance: Resistance1: 244.99    Resistance2: 286.15
Pivot: 239.72
Moving Average: MA(5): 240.12     MA(20): 240.40
MA(100): 217.74     MA(250): 197.65
MACD: MACD(12,26): 1.73     Signal(9): 2.20
Stochastic oscillator: %K(14,3): 71.68     %D(3): 63.24
RSI: RSI(14): 60.56
52-week: High: 244.99  Low: 166.30  Change(%): 19.6
Average Vol(K): 3-Month: 219302  10-Days: 195036

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AMGN has closed below upper band by 19.1%. Bollinger Bands are 61.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMGN's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-01-17
Serine Threonine Protein Kinase Pim 2, Pipeline Review, H2 2019: Amgen Inc, Inflection Biosciences Ltd & Zovis Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Serine Threonine Protein Kinase Pim 2 - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Summary According to the recently published report 'SerineThreonine Protein Kinase Pim 2 - Pipeline Review, H2 2019'; Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) pipeline Target constitutes close to 10 molecules. Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or

2020-01-16
Should Value Investors Consider Amgen (AMGN) Stock Now?
Let's see if Amgen (AMGN) stock is a good choice for value-oriented investors right now from multiple angles.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 594.18
Shares Float (M) 592.88
% Held by Insiders 0.21
% Held by Institutions 79.57
Shares Short (K) 9020
Shares Short P. Month (K)

Stock Financials

EPS 13.000
Book Value (p.s.) 18.330
PEG Ratio 2.07
Profit Margin 34.48
Operating Margin 42.60
Return on Assets (ttm) 9.8
Return on Equity (ttm) 63.8
Qtrly Rev. Growth -2.8
Gross Profit (p.s.) 33.071
Sales Per Share
EBITDA (p.s.) 20.129
Qtrly Earnings Growth 5.90
Operating Cash Flow (M) 9830.00
Levered Free Cash Flow (M) 6440.00

Stock Valuations

P/E 18.58
P/E Growth Ratio
P/BV 13.17
P/S 6.35
P/CF 14.60

Dividends & Splits

Dividend 5.670
Dividend Yield 0.02
Dividend Pay Date 2020-03-06
Ex-Dividend Date 2020-02-13
Forward Dividend 6.400
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.